Jeffrey GruenglasExecutive Vice President, Oncology Business Unit
Jeff is a life sciences professional with more than 15 years of experience in market development, commercialization, and life-cycle management.
Jeff developed and leads the Oncology Business Unit at The Access Group. His expertise spans compounds, modalities, and diagnostics for solid tumors, hematologic malignancies, supportive care, and advocacy. In this role, Jeff develops strategic frameworks and consults on policy and market dynamics that drive delivery of cancer care, utilization, and access for pharmaceutical and biotech clients.
Prior to this, Jeff created and led the oncology practice at Havas, a global media and communications network. During his tenure, he held various roles with increasing responsibility across creative, client services, and strategic functions in New York, New Jersey, and Boston.
A former New York creative director, Jeff has received numerous industry awards for science visualization and creative campaigns. He has been profiled by industry publications and has served as judge on award committees.
Jeff holds Master’s and Bachelor’s degrees in English Literature and Critical Theory from City University of New York-Brooklyn College. He is completing his Masters of Bioethics, focused on industry ethics and healthcare policy, from Harvard University.